INmuneBIO Company

INmune Bio, Inc. is developing therapies that harness the patient’s immune system to treat cancer.
Technology: Other
Industry: P4 Medicine
Headquarters: Others
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: $48.2M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Equity

Visit Website
dmoss@inmunebio.com
https://twitter.com/INmuneBio
Register and Claim Ownership